Current applications of monoclonal antibodies for the therapy of hematopoietic cancers Journal Article


Author: Scheinberg, D. A.
Article Title: Current applications of monoclonal antibodies for the therapy of hematopoietic cancers
Abstract: Recent trials of monoclonal antibodies in patients with leukemias or lymphomas have demonstrated the remarkable potency of these agents to kill tumor cells specifically and safely. New molecular biological and radiochemical techniques are also allowing rapid inroads into the remaining obstacles to this mode of therapy. © 1991.
Keywords: leukemia; review; t lymphocyte; animal; mice; in vitro study; monoclonal antibody; antibodies, monoclonal; lymphoma; tumor cell; radioimmunotherapy; antibodies, neoplasm; therapy; granulocyte; vaccines; antibody dependent cellular cytotoxicity; radiochemistry; receptors, cell surface; hematopoietic system tumor; immunotoxins; antibodies, anti-idiotypic; protein engineering; immunoglobulin idiotypes; cancer; human; support, non-u.s. gov't; hematopoietic cell growth factors
Journal Title: Current Opinion in Immunology
Volume: 3
Issue: 5
ISSN: 0952-7915
Publisher: Elsevier Inc.  
Date Published: 1991-10-01
Start Page: 679
End Page: 684
Language: English
DOI: 10.1016/0952-7915(91)90096-j
PUBMED: 1661602
PROVIDER: scopus
DOI/URL:
Notes: Article -- Export Date: 27 September 2019 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors